BillionToOne, Inc. BLLN
Set alert
As of Nov 2, 2:25 PM ET
- YTD
- +32.09%
- 1 year
- -0.77%
- Open
- 113.17
- Prev close
- 113.32
- Mkt cap
- 5.12B
- Vol
- 353.73K
- Avg vol
- 654.34K
- EPS
- 0.63
- P/E
- 172.12
- Div yield
- 0.00%
More statistics
- Low
- 106.72
- High
- 114.07
- Forward P/E
- 76.31
- Beta
- 0.00
- Short ratio
- 4.68
- Inst. own
- 45.39%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 103.45
- 200-d avg
- 96.34
- 1y target
- 129.00
5D chart
Signals (152)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 3:45 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:40 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 12:50 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:20 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 12:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:25 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:25 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:05 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:40 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:30 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:20 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 3 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:25 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 3:20 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 3:05 PM | 4 days ago |
| SMA: Bearish | Oct 29, 2:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 2:25 PM | 4 days ago |
| SMA: Bullish | Oct 29, 2:15 PM | 4 days ago |
| RSI: Oversold | Oct 29, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 1:15 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 4 days ago |
| SMA: Bullish | Oct 29, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:45 PM | 4 days ago |
| SMA: Bullish | Oct 29, 12:25 PM | 4 days ago |
| SMA: Bullish | Oct 29, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 29, 11:55 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:15 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:10 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 11:10 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:55 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 10:40 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:10 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 9:50 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:40 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:25 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:20 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:05 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 2:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 2:50 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:35 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:10 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 2:10 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 1:45 PM | 5 days ago |
| SMA: Bearish | Oct 28, 1:35 PM | 5 days ago |
| SMA: Bearish | Oct 28, 1:35 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 12:50 PM | 5 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:15 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:10 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:40 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:25 AM | 5 days ago |
| RSI: Overbought | Oct 28, 10:10 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:50 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 9:40 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 3:50 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:10 PM | 6 days ago |
| MACD: Sell Signal | Oct 27, 3:00 PM | 6 days ago |
| MACD: Buy Signal | Oct 27, 2:25 PM | 6 days ago |
| SMA: Bullish | Oct 27, 2:05 PM | 6 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 6 days ago |
| SMA: Bearish | Oct 27, 1:55 PM | 6 days ago |
| MACD: Sell Signal | Oct 27, 1:45 PM | 6 days ago |
| SMA: Bearish | Oct 27, 1:40 PM | 6 days ago |
| RSI: Overbought | Oct 27, 1:15 PM | 6 days ago |
| MACD: Buy Signal | Oct 27, 1:10 PM | 6 days ago |
| MACD: Sell Signal | Oct 27, 1:00 PM | 6 days ago |
| MACD: Buy Signal | Oct 27, 12:45 PM | 6 days ago |
| SMA: Bearish | Oct 27, 12:00 PM | 6 days ago |
| SMA: Bullish | Oct 27, 11:35 AM | 6 days ago |
| MACD: Sell Signal | Oct 27, 11:35 AM | 6 days ago |
| SMA: Bearish | Oct 27, 11:20 AM | 6 days ago |
| RSI: Overbought | Oct 27, 10:45 AM | 6 days ago |
| SMA: Bullish | Oct 27, 10:35 AM | 6 days ago |
| MACD: Buy Signal | Oct 27, 10:35 AM | 6 days ago |
| MACD: Sell Signal | Oct 27, 10:20 AM | 6 days ago |
| SMA: Bearish | Oct 27, 10:15 AM | 6 days ago |
| SMA: Bullish | Oct 27, 9:35 AM | 6 days ago |
| SMA: Bullish | Oct 27, 9:35 AM | 6 days ago |
| MACD: Buy Signal | Oct 27, 9:35 AM | 6 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 6 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 6 days ago |
| MACD: Sell Signal | Oct 27, 9:30 AM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:35 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:20 PM | 1 week ago |
| SMA: Bullish | Oct 26, 3:15 PM | 1 week ago |
| SMA: Bullish | Oct 26, 3:10 PM | 1 week ago |
| SMA: Bearish | Oct 26, 2:40 PM | 1 week ago |
| SMA: Bearish | Oct 26, 2:25 PM | 1 week ago |
| SMA: Bullish | Oct 26, 2:15 PM | 1 week ago |
| SMA: Bearish | Oct 26, 2:10 PM | 1 week ago |
| MACD: Sell Signal | Oct 26, 2:10 PM | 1 week ago |
| MACD: Buy Signal | Oct 26, 1:55 PM | 1 week ago |
| SMA: Bullish | Oct 26, 1:40 PM | 1 week ago |
| SMA: Bearish | Oct 26, 1:25 PM | 1 week ago |
| MACD: Sell Signal | Oct 26, 1:25 PM | 1 week ago |
| MACD: Buy Signal | Oct 26, 1:15 PM | 1 week ago |
| MACD: Sell Signal | Oct 26, 1:05 PM | 1 week ago |
| MACD: Buy Signal | Oct 26, 12:55 PM | 1 week ago |
| SMA: Bullish | Oct 26, 12:20 PM | 1 week ago |
| SMA: Bearish | Oct 26, 12:15 PM | 1 week ago |
| SMA: Bullish | Oct 26, 12:10 PM | 1 week ago |
| SMA: Bearish | Oct 26, 11:35 AM | 1 week ago |
| SMA: Bullish | Oct 26, 11:15 AM | 1 week ago |
| SMA: Bearish | Oct 26, 11:10 AM | 1 week ago |
News
4 days ago seekingalpha.com
BillionToOne: New Kid On The Molecular Diagnostics Block Poised To Take Share
BillionToOne, Inc. is disrupting molecular diagnostics, leveraging proprietary smNGS technology for rapid growth and a $5.2B market cap. BLLN's Unity Complete offers unmatched prenatal screening…
5 days ago zacks.com
BillionToOne (BLLN) Reports Next Week: Wall Street Expects Earnings Growth
BillionToOne (BLLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
6 days ago globenewswire.com
BillionToOne to Participate in Two Upcoming Investor Conferences
MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are…
2 weeks ago defenseworld.net
Billiontoone (NASDAQ:BLLN) CEO Sells $516,184.50 in Stock
Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) CEO Oguzhan Atay sold 5,150 shares of the business's stock in a transaction dated Thursday, October 15th. The shares were sold at an average price…
2 weeks ago globenewswire.com
BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026
MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are…
2 weeks ago seekingalpha.com
BillionToOne: A Molecular Diagnostics Stock With Strong Quality And GARP Credentials
BillionToOne a molecular diagnostic company from California, has experienced quite a topsy-turvey journey since its debut in November last year. BLLN is set to hold on to a consistently high GMS of…
3 weeks ago globenewswire.com
BillionToOne's Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds
Head-to-head comparison shows 94% concordance with tumor-informed ctDNA testing, with the clinical ground-truth in all discordant cases supporting Northstar Response Head-to-head comparison shows 94%…
1 month ago defenseworld.net
Billiontoone (NASDAQ:BLLN) Shares Down 4.6% After Insider Selling
Shares of Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) were down 4.6% on Wednesday after an insider sold shares in the company. The stock traded as low as $112.75 and last traded at $112.72.…
-
1 month ago benzinga.com
Guggenheim Maintains Buy on BillionToOne, Raises Price Target to $128
Guggenheim analyst Subbu Nambi maintains BillionToOne (NASDAQ:BLLN) with a Buy and raises the price target from $125 to $128.
1 month ago benzinga.com
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
The Centers for Medicare & Medicaid Services plans to align its 2027 clinical laboratory fee schedule rates with private sector payer rates, aiming to curb excessive Medicare payments and save…
1 month ago benzinga.com
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.
1 month ago fool.com
BillionToOne SVP Sells 1,416 Shares
The transaction involved 1,416 shares at a weighted average price of $97.54 per share, totaling $138,116 on Sept. 9, 2026. The sale involved shares equal to 5% of the direct equity position held…
1 month ago fool.com
BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million
The transaction involved 30,331 shares executed at a weighted average price of $99.91 per share on September 14, 2026. The shares traded in this filing represented 100% of the insider's directly-held…
2 months ago prnewswire.com
BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference
MENLO PARK, Calif., Sept. 2, 2026 /PRNewswire/ -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are…
-
2 months ago benzinga.com
Canaccord Genuity Initiates Coverage On BillionToOne with Buy Rating, Announces Price Target of $120
Canaccord Genuity analyst Kyle Mikson initiates coverage on BillionToOne (NASDAQ:BLLN) with a Buy rating and announces Price Target of $120.
2 months ago prnewswire.com
BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin
New add-on test from a single blood draw; BillionToOne also expands Northstar Select® panel to 102 genes MENLO PARK, Calif., Sept. 1, 2026 /PRNewswire/ -- BillionToOne, Inc. (Nasdaq: BLLN), a…
2 months ago fool.com
BillionToOne's Co-Founder Sells 10,000 Shares for $1 Million
The transaction involved 10,000 shares at a weighted-average price of $100.00 per share, totaling $1.0 million on the August 25, 2026 transaction date. Following the disposal, the insider holds a…
2 months ago benzinga.com
Jim Cramer: 'You Could Make Some Money With This 5.6% Yield'
Jim Cramer likes Babcock & Wilcox and Smithfield Foods. He also advises taking some profits on BillionToOne, and calls Eton Pharma a winner.
2 months ago gurufocus.com
/C O R R E C T I O N -- BillionToOne/
/C O R R E C T I O N -- BillionToOne/ PR Newswire MENLO PARK, Calif., Aug. 18, 2026 I
-
2 months ago benzinga.com
BillionToOne Publishes NIPT Study Titled A Prospective, Multi-Site Study Of Performance Of Cell-Free DNA Testing For Recessive Conditions In A Large, General-Risk Pregnancy Population
BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced publication of A…
2 months ago prnewswire.com
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
Study of more than 2,200 pregnant carriers demonstrates strong clinical performance in the intended-use, general-risk population, with outcomes available for more than 98% of eligible cfDNA results…
2 months ago defenseworld.net
Billiontoone, Inc. (NASDAQ:BLLN) Receives $126.71 Average PT from Brokerages
Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the ten analysts that are covering the stock, MarketBeat Ratings reports. One investment…
2 months ago seekingalpha.com
BillionToOne: A Softer Quarter After Heightened Expectations
BillionToOne experienced a sharp post-earnings sell-off despite maintaining full-year guidance and strong year-over-year revenue growth. Second quarter results showed slowing sequential growth,…
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday's regular session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC)…
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's pre-market session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC)…
-
2 months ago benzinga.com
BTIG Maintains Buy on BillionToOne, Lowers Price Target to $130
BTIG analyst Mark Massaro maintains BillionToOne (NASDAQ:BLLN) with a Buy and lowers the price target from $142 to $130.
2 months ago benzinga.com
BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move
BillionToOne stock fell after hours after reporting second-quarter financial results.
2 months ago zacks.com
BillionToOne (BLLN) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for BillionToOne (BLLN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics…
2 months ago marketbeat.com
Billiontoone Q2 Earnings Call Highlights
Billiontoone NASDAQ: BLLN reported second-quarter 2026 revenue growth of 64% year over year, driven by higher testing volumes and average selling prices across its prenatal and oncology businesses.…
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences…
-
2 months ago benzinga.com
BillionToOne Affirms FY2026 Sales Guidance of $450.000M-$465.000M vs $456.440M Est
BillionToOne (NASDAQ:BLLN) affirms FY2026 sales outlook from $450.000 million-$465.000 million to $450.000 million-$465.000 million vs $456.440 million estimate.
-
2 months ago benzinga.com
BillionToOne Q3 EPS $0.15 Misses $0.19 Estimate, Sales $109.400M Beat $109.365M Estimate
BillionToOne (NASDAQ:BLLN) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.19 by 21.05 percent. This is a 50 percent increase over earnings of $0.10…
-
4 months ago benzinga.com
Guggenheim Initiates Coverage On BillionToOne with Buy Rating, Raises Price Target to $125
Guggenheim analyst Subbu Nambi initiates coverage on BillionToOne (NASDAQ:BLLN) with a Buy rating and raises Price Target to $125.
5 months ago benzinga.com
Jim Cramer: Design Therapeutics Is 'Pure Spec,' Buy This Health Care Stock
Cramer likes Silicon Motion, whose shares fell 2.2% to settle at $263.85 on Thursday. Wynn shares declined 0.8% to close at $95.43.
6 months ago benzinga.com
Joby Aviation Is 'Too Risky,' But This Industrial Stock Is A 'Winner': Jim Cramer
Cramer shared his thoughts on various stocks, calling Joby Aviation too risky, BillionToOne a winner, Boston Scientific caught in competition, Rocket Lab a winner, and Pinnacle West Capital a good…
8 months ago benzinga.com
Marriott Vacations To Rally Around 52%? Here Are 10 Top Analyst Forecasts For Thursday
Summary:Top Wall Street analysts changed outlook on top names. Analyst ratings page shows all changes. VEEV, GENI, DOW, BLLN, OKTA, VAC, WLK, EYPT had price target changes.
-
-
10 months ago benzinga.com
Earnings Scheduled For December 9, 2025
Earnings Scheduled For December 9, 2025
11 months ago benzinga.com
ServiceTitan Posts Upbeat Q3 Results, Joins DigitalBridge, Rubrik, Victoria's Secret And Other Big Stocks Moving Higher On Friday
ServiceTitan Posts Upbeat Q3 Results, Joins DigitalBridge, Rubrik, Victoria's Secret And Other Big Stocks Moving Higher On Friday
11 months ago benzinga.com
This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday